Unknown PHASE2 INTERVENTIONAL NCT00002531

Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

MULTICENTRE TRIAL OF INTENSIFIED THERAPY FOR ADULT ALL (O5/93)

Sponsor: Johann Wolfgang Goethe University Hospital

Conditions Leukemia

Updated 5 times since 2017 Last updated: Sep 16, 2013 Started: Jan 31, 1993

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00002531, this PHASE2 trial focuses on Leukemia and remains ongoing. Sponsored by Johann Wolfgang Goethe University Hospital, it has been updated 5 times since 1993, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Jan 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johann Wolfgang Goethe University Hospital

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Frankfurt, Germany